EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors

Keshuang Zheng, Yongpu Feng, Lei Li, Fanyang Kong, Jie Gao, Xiangyu Kong

Theranostics · 2024 · 14 (2) · 761-787

DOI: 10.7150/thno.85917 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, 2024. Verfasst von Keshuang Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Immunology and Inflammation, Naval Medical University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Vaccines, Extracellular Vesicles, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 90-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Outer membrane vesicles (OMVs) are nanoscale lipid bilayer structures released by gram-negative bacteria. They share membrane composition and properties with their originating cells, making them adept at traversing cellular barriers. These OMVs have demonstrated exceptional membrane stability, immunogenicity, safety, penetration, and tumor-targeting properties, which have been leveraged in developing vaccines and drug delivery systems. Recent research efforts have focused on engineering OMVs to increase production yield, reduce cytotoxicity, and improve the safety and efficacy of treatment. Notably, gastrointestinal (GI) tumors have proven resistant to several traditional oncological treatment strategies, including chemotherapy, radiotherapy, and targeted therapy. Although immune checkpoint inhibitors have demonstrated efficacy in some patients, their usage as monotherapy remains limited by tumor heterogeneity and individual variability. The immunogenic and modifiable nature of OMVs makes them an ideal design platform for the individualized treatment of GI tumors. OMV-based therapy enables combination therapy and optimization of anti-tumor effects. This review comprehensively summarizes recent advances in OMV engineering for GI tumor therapy and discusses the challenges in the clinical translation of emerging OMV-based anti-tumor therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaccinesExtracellular VesiclesGastrointestinal NeoplasmsHumansBacterial Outer MembraneBacteriaBacterial Outer Membrane Proteins

Stichwörter der Autor:innen

cargo deliverygastrointestinal tumorsgenetic engineeringouter membrane vesiclestumor vaccine

Substanzen

VaccinesBacterial Outer Membrane Proteins

Autor:innen und Institutionen

  • National Key Laboratory of Immunology and Inflammation, Naval Medical University, Shanghai, 200433, China.
  • Institute of Neuroscience, Key Laboratory of Molecular Neurobiology of the Ministry of Education and the Collaborative Innovation Center for Brain Science, Naval Medical University, Shanghai, 200433, China.
  • Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Digestive Endoscopy Center, Shanghai Tenth People's Hospital, Shanghai, China.
  • Changhai Clinical Research Unit, Changhai Hospital, Naval Medical University, Shanghai, China.

Zitieren

APA

Zheng, K., Feng, Y., Li, L., Kong, F., Gao, J., & Kong, X. (2024). Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors. Theranostics, 14(2), 761-787. https://doi.org/10.7150/thno.85917

Vancouver

Zheng K, Feng Y, Li L, Kong F, Gao J, Kong X. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors. Theranostics. 2024;14(2):761-787. doi:10.7150/thno.85917

BibTeX
@article{Zheng2024,
  author = {Zheng, Keshuang and Feng, Yongpu and Li, Lei and Kong, Fanyang and Gao, Jie and Kong, Xiangyu},
  title = {Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {2},
  pages = {761--787},
  doi = {10.7150/thno.85917}
}
Kostenlos starten →